<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="brief-report" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Frontiers in Psychiatry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Psychiatry</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1664-0640</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpsyt.2026.1751247</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Research Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Circulating phospholipid species and internet addiction severity in Japanese adolescents: a pilot lipidomics study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Kawahara</surname><given-names>Tomoki</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3289024/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Tani</surname><given-names>Yukako</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/301789/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Nawa</surname><given-names>Nobutoshi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/903572/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Morioka</surname><given-names>Shin</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Kajiho</surname><given-names>Hiroaki</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Sasaki</surname><given-names>Junko</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Sasaki</surname><given-names>Takehiko</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2147144/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Fujiwara</surname><given-names>Takeo</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/213555/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project-administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Public Health, Institute of Science Tokyo</institution>, <city>Tokyo</city>,&#xa0;<country country="jp">Japan</country></aff>
<aff id="aff2"><label>2</label><institution>Department of Clinical Information Applied Sciences, Institute of Science Tokyo</institution>, <city>Tokyo</city>,&#xa0;<country country="jp">Japan</country></aff>
<aff id="aff3"><label>3</label><institution>Department of Biochemical Pathophysiology, Institute of Science Tokyo</institution>, <city>Tokyo</city>,&#xa0;<country country="jp">Japan</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Tomoki Kawahara, <email xlink:href="mailto:kawahara.hlth@tmd.ac.jp">kawahara.hlth@tmd.ac.jp</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-16">
<day>16</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>17</volume>
<elocation-id>1751247</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>20</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Kawahara, Tani, Nawa, Morioka, Kajiho, Sasaki, Sasaki and Fujiwara.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Kawahara, Tani, Nawa, Morioka, Kajiho, Sasaki, Sasaki and Fujiwara</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-16">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Internet addiction is increasing among adolescents, yet biological markers remain scarce. Lipid metabolism influences neurobehavior, but its association with internet addiction is unclear. Plasma concentrations of 150 phospholipid species from eight classes&#x2014;phosphatidylinositol (PI), PI3P, PI4P, PI(3,5)P<sub>2</sub>, PI(4,5)P<sub>2</sub>, phosphatidylethanolamine (PE), phosphatidylcholine (PC), and PIP<sub>3</sub>&#x2014;were quantified in 34 Japanese adolescents (mean &#xb1; SD age = 16.4 &#xb1; 0.5 y) using targeted LC-MS/MS with isotopic internal standards. Internet addiction severity was assessed by the 20-item Internet Addiction Test (IAT; range 0&#x2013;100). Associations between lipid species and IAT scores were examined using linear regression adjusted for sex, with false-discovery-rate (FDR) correction for multiple testing. Several PE and PC species showed significant associations with IAT. In particular, PE 36:4 (&#x3b2; = 5.00, 95% CI 1.67&#x2013;8.33, q = 0.042) and PE 36:2 (&#x3b2; = &#x2013;1.33, 95% CI &#x2013;2.29 to &#x2013;0.38, q = 0.042) were among the strongest indicators. Additional suggestive associations were observed for PE 38:3, PE 40:5, and PC 38:3. Specific circulating PE and PC species are associated with internet addiction severity in Japanese adolescents. These preliminary findings highlight lipid dysregulation as a potential biomarker for problematic internet use and warrant confirmation in larger, longitudinal studies.</p>
</abstract>
<kwd-group>
<kwd>adolescents</kwd>
<kwd>internet addiction test</kwd>
<kwd>lipidomics</kwd>
<kwd>phosphatidylcholine</kwd>
<kwd>phosphatidylethanolamine</kwd>
<kwd>plasma</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This work was supported by JSPS KAKENHI Grant Numbers 21H04848, 21K18294, 22H05103, and 24K02664; JST RISTEX Grant Number JPMJRS24K2; AMED-CREST Grant Number JP25gm1710007; Nanken-Kyoten; the Multilayered Stress Diseases program; and the Initiative for High Depth Omics, Institute of Science Tokyo.</funding-statement>
</funding-group>
<counts>
<fig-count count="3"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="17"/>
<page-count count="7"/>
<word-count count="3752"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Addictive Disorders</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Internet addiction has become a global public-health concern. A recent meta-analysis that pooled data from &gt;2 million individuals across 64 countries estimated that ~14% of the world&#x2019;s population meets criteria for generalized Internet addiction, with higher figures for smartphone and social-media overuse (<xref ref-type="bibr" rid="B1">1</xref>). In Japan, longitudinal school-based data show an annual incidence of 22% for new-onset Internet addiction among adolescents aged 15&#x2013;16 years (<xref ref-type="bibr" rid="B2">2</xref>). These incidences coincide with the developmental window in which reward sensitivity peaks and executive control is still maturing, underscoring the need to identify biological markers that might signal heightened vulnerability.</p>
<p>Phospholipids are integral to neuronal membrane architecture and signaling. Disturbances in both brain and peripheral lipid classes&#x2014;particularly phosphatidylethanolamine (PE), phosphatidylcholine (PC), and phosphatidylinositol bisphosphate (PIP<sub>2</sub>)&#x2014;have been documented across various psychiatric conditions. Reviews have highlighted altered phospholipid composition across mood, psychotic, and substance-use disorders (<xref ref-type="bibr" rid="B3">3</xref>). Experimentally, elevated platelet PIP<sub>2</sub> levels have been observed in depressed bipolar patients (<xref ref-type="bibr" rid="B4">4</xref>), and brains of individuals with Alzheimer&#x2019;s disease show marked reductions in PE plasmalogens (<xref ref-type="bibr" rid="B5">5</xref>). Circulating lysophosphatidic acid and lysophosphatidylcholine species have been linked to affective symptomatology, although findings remain equivocal (<xref ref-type="bibr" rid="B6">6</xref>). Importantly, untargeted lipidomics of young adults with Internet gaming disorder revealed specific PE and PC species that distinguished affected individuals from controls, suggesting a lipidome&#x2013;behavior association that extends to digital-use phenotypes (<xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>To date, no study has examined whether quantitative differences in canonical phospholipid fractions (PE, PC, and phosphoinositide derivatives) are associated with the severity of Internet addiction in a non-clinical youth cohort. The absence of data is notable, given that these phospholipids modulate synaptic plasticity and dopaminergic signaling pathways implicated in reward-seeking behaviors. Addressing this gap could yield potential biomarkers for early detection and mechanistic insights.</p>
<p>Using targeted quantitative lipidomics, we investigated the associations between plasma PE, PC, and phosphoinositide profiles and Internet Addiction Test (IAT) scores in Japanese adolescents aged 16&#x2013;17 years. We hypothesized that specific phospholipid species would exhibit significant associations with IAT-defined Internet dependence after adjustment for socioeconomic, lifestyle, and psychosocial covariates.</p>
</sec>
<sec id="s2">
<title>Methods</title>
<sec id="s2_1">
<title>Study design and population</title>
<p>This study recruited participants from the A-CHILD study and surveyed them when they were 16&#x2013;17 years old (A-CHILD NEXT study). A consent form was mailed to the participants with the survey instructions and written consent was obtained. The subjects were minors, and consent was also obtained from their parent or caregivers. Cross-sectional data came from the A-CHILD NEXT follow-up (Adachi City, Tokyo). Of 34 participants with complete lipid and questionnaire data (2019 n = 14; 2021 n = 20), mean age was 16.4 y (SD 0.5); 59% were male. At the study visit, participants completed self-administered questionnaires and underwent fasting venous blood sampling. Participants who provided a blood sample received a 5000-yen honorarium. The Institute of Science Tokyo (formerly Tokyo Medical and Dental University) Ethics Committee approved the protocol (M2017-110); written assent and parental consent were obtained.</p>
</sec>
<sec id="s2_2">
<title>Phospholipid profiling</title>
<p>Fasting venous blood samples were collected at the study site and processed to obtain plasma for phospholipid profiling. Fasted plasma phospholipids were quantified by targeted liquid chromatography&#x2013;tandem mass spectrometry (LC&#x2013;MS/MS) using a reverse-phase column for phosphatidylcholine (PC) and phosphatidylethanolamine (PE), and a chiral column for phosphoinositides.</p>
<p>For PC and PE measurements, 2 &#xb5;L of plasma was mixed with 1.2 mL methanol containing 10 pmol each of C12:0/C13:0 PC and C12:0/C13:0 PE as internal standards, which possess odd-numbered fatty acyl chains absent in mammalian plasma and shorter chain lengths that yield distinct retention times from endogenous phospholipids. Subsequently, 600 &#xb5;L ultrapure water, 600 &#xb5;L 2 M HCl, and 100 &#xb5;L 1 M NaCl were added. After thorough vortex-mixing, 2 mL chloroform was added, and the mixture was vortexed again for 2 min. The solution was centrifuged at 1200 &#xd7; g for 4 min at room temperature, and the lower organic phase was collected and transferred to a fresh glass tube. The lipid extract was dried under a stream of nitrogen and reconstituted in 800 &#xb5;L chloroform/methanol (1:1). For derivatization, 150 &#xb5;L 0.6 M trimethylsilyl diazomethane was added to the fraction at room temperature. After 10 min, the reaction was quenched with 20 &#xb5;L glacial acetic acid. The samples were mixed with 400 &#xb5;L chloroform and 400 &#xb5;L ultrapure water, vortexed for 1 min, and centrifuged at 1200 &#xd7; g for 4 min. The lower phase was dried under nitrogen and redissolved in 400 &#xb5;L methanol/ultrapure water (3:1). An aliquot (10 &#xb5;L) was injected for analysis. Reverse-phase LC&#x2013;MS/MS was performed using a QTRAP 6500 triple quadrupole mass spectrometer (AB SCIEX) coupled to a Nexera X2 HPLC system (Shimadzu) with a PAL HTC-xt autosampler (CTC Analytics). Separation of phospholipids employed an InertSustainBio C18 column (2.1 &#xd7; 150 mm, 1.9 &#xb5;m; GL Sciences) at 60 &#xb0;C. The mobile phases consisted of (A) isopropanol/1 M ammonium acetate (200:1) and (B) methanol/acetonitrile/ultrapure water/1 M ammonium acetate (90:90:20:1). The flow rate was 100 &#xb5;L/min with the following gradient: 0&#x2013;2 min, 10% A; 2&#x2013;4 min, 10&#x2013;40% A; 4&#x2013;11 min, 40&#x2013;55% A; 11&#x2013;17 min, 55&#x2013;82% A; 17&#x2013;21 min, 82% A; and 21&#x2013;29 min, 10% A. Multiple reaction monitoring (MRM) transitions (precursor/product ion pairs) are listed in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;2</bold></xref>. Data were acquired using Analyst 1.6.3 (AB SCIEX) and processed in MultiQuant (AB SCIEX) for manual peak integration. No background subtraction was applied. Gaussian smoothing width was set to 1.0 point. Quantification was based on the ratio of sample peak area to internal standard peak area.</p>
<p>For phosphoinositide [PI, PI3P, PI4P, PI (3,5)P<sub>2</sub>, PI (4,5)P<sub>2</sub>, and PIP<sub>3</sub>] analyses, lipid extraction was performed as described previously (<xref ref-type="bibr" rid="B8">8</xref>). 100 &#xb5;L plasma was mixed with 1.5 mL methanol. To this suspension, 50 &#xb5;L of methanol/chloroform (9:1) containing 1 nmol C8:0/C8:0 PI (4,5)P<sub>2</sub> (used as an adsorption inhibitor) and 10 pmol each of synthetic C17:0/C20:4 phosphoinositides (internal standards) were added. Subsequently, 750 &#xb5;L ultrapure water, 750 &#xb5;L 2 M HCl, and 200 &#xb5;L 1 M NaCl were added. After vortex-mixing, 3 mL chloroform was added, followed by an additional 2 min vortex. The mixture was centrifuged at 1200 &#xd7; g for 4 min at room temperature. The lower organic phase containing crude lipids was transferred to a clean glass tube. Phosphoinositides were preconcentrated using a DEAE Sepharose Fast Flow anion-exchange resin (10% slurry). The resin was sequentially washed twice with ultrapure water, once with 1 M HCl, twice with water, once with 1 M NaOH, and twice again with water, then resuspended in methanol to form a 50% slurry. A 0.5 mL bed volume was packed into a Pasteur pipette plugged with glass wool. The crude lipid extract (2.9 mL) mixed with 1.5 mL methanol was applied to the column. The column was washed with 3 mL chloroform/methanol (1:1) and 2 mL chloroform/methanol/28% aqueous ammonia/glacial acetic acid (200:100:3:0.9). Elution was performed with 1.5 mL chloroform/methanol/12 M HCl/ultrapure water (12:12:1:1). The eluted fraction was mixed with 850 &#xb5;L 120 mM NaCl and centrifuged at 1200 &#xd7; g for 4 min at room temperature. The lower phase containing purified phosphoinositides was collected. For derivatization, 150 &#xb5;L 0.6 M trimethylsilyl diazomethane was added to the purified fraction at room temperature. After 10 min, the reaction was quenched with 20 &#xb5;L glacial acetic acid. The samples were mixed with 700 &#xb5;L methanol/ultrapure water/chloroform (48:47:3), vortexed for 1 min, and centrifuged at 1200 &#xd7; g for 4 min. The lower phase was dried under nitrogen and redissolved in 100 &#xb5;L acetonitrile. LC&#x2013;MS/MS analysis was performed as described above for PC and PE analysis. A 10 &#xb5;L aliquot was injected, and separation was achieved on a CHIRALPAK IC-3 column (2.1 &#xd7; 250 mm, 3 &#xb5;m; DAICEL) at 22 &#xb0;C. Chromatography was carried out at a flow rate of 100 &#xb5;L/min with the following gradient: 40% mobile phase A (methanol/5 mM ammonium acetate) and 60% mobile phase B (acetonitrile/5 mM ammonium acetate) for 1 min, linearly increasing to 85% A over 2 min, and held at 85% A for 11 min. MRM transitions are listed in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;3</bold></xref>. Acquired data were analyzed using Analyst 1.6.3 (AB SCIEX) and MultiQuant (AB SCIEX), as described above for PC and PE analysis. Features failing laboratory quality control were excluded. Transitions not meeting laboratory quality control criteria, such as undetectable peaks at the noise level, were excluded from quantification, and their values were assigned as zero. For each molecular species, abundance was expressed as the ratio of analyte peak area to its isotopic internal standard (arbitrary units); no external calibration was performed. Reported values therefore represent internal&#x2212;standard&#x2013;normalized intensities.</p>
</sec>
<sec id="s2_3">
<title>Internet-addiction test</title>
<p>The 20-item IAT (range 0&#x2013;100; validated Japanese version) was administered using the validated Japanese translation (JIAT) (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). The primary outcome was the continuous IAT score. For descriptive categorization, IAT scores &#x2265;40 were treated as at least moderate dependence, consistent with the conventional thresholds adopted in Japan and prior work using the IAT (<xref ref-type="bibr" rid="B11">11</xref>).</p>
</sec>
<sec id="s2_4">
<title>Statistical analysis</title>
<p>Analyses used Python 3.11.10 (pandas 2.2.2; statsmodels 0.14). For each lipid species within each class, we fit a sex-adjusted ordinary least-squares model with IAT as the outcome (complete-case per lipid). We report the regression coefficient (<inline-formula>
<mml:math display="inline" id="im1"><mml:mi>&#x3b2;</mml:mi></mml:math></inline-formula> per unit of lipid abundance), 95% CI, and p-value. Multiple testing was controlled within lipid class using Benjamini&#x2013;Hochberg false-discovery rate (FDR); q&lt;0.05 indicated statistical evidence and 0.05&#x2264;q&lt;0.30 was treated as exploratory (<xref ref-type="bibr" rid="B12">12</xref>). We controlled multiplicity within lipid class using the Benjamini&#x2013;Hochberg procedure. The number of tests (m) per class was: PI (m = 16), PI3P (12), PI4P (16), PI(3,5)P<sub>2</sub> (17), PI(4,5)P<sub>2</sub> (16), PIP<sub>3</sub> (5), PC (15), and PE (15). <inline-formula>
<mml:math display="inline" id="im2"><mml:mi>&#x3b2;</mml:mi></mml:math></inline-formula> reflects the mean difference in IAT score per one&#x2212;unit increase in the IS&#x2212;normalized ratio (a.u.). Figures comprise a volcano plot of <inline-formula>
<mml:math display="inline" id="im3"><mml:mi>&#x3b2;</mml:mi></mml:math></inline-formula> versus &#x2212;log10(q) and a two-panel display (scatter with fitted line; IAT by lipid quartiles) for the lipid with the smallest q. Two-sided <inline-formula>
<mml:math display="inline" id="im4"><mml:mi>&#x3b1;</mml:mi></mml:math></inline-formula>=0.05.</p>
</sec>
<sec id="s2_5">
<title>Ethics statement</title>
<p>The A&#x2212;CHILD NEXT follow&#x2212;up was approved by the Institute of Science Tokyo Research Ethics Committee (M2017&#x2212;110). Parents or legal guardians provided written informed consent; adolescents provided written assent before any study procedures. No incentives were contingent on survey responses, and participation could be discontinued at any time without penalty.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Participant characteristics</title>
<p>Among 34 adolescents (59% male; mean &#xb1; SD age 16.4 &#xb1; 0.5 years), the mean Internet-Addiction Test (IAT) score was 47.9 &#xb1; 13.4 (range 24&#x2013;71). Two participants scored &#x2265;70, which is classified as &#x201c;severe&#x201d; on the Internet Addiction Test and indicates that Internet use may cause major problems in daily life (<xref ref-type="bibr" rid="B13">13</xref>). Using the descriptive threshold of IAT &#x2265;40, 28/34 (82%) met criteria for at least moderate dependence. IAT did not differ by sex (p=0.91). Parental divorce or bereavement was uncommon (18%), and most households reported annual income <inline-formula>
<mml:math display="inline" id="im5"><mml:mo>&#x2265;</mml:mo></mml:math></inline-formula> 600,000 JPY (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;1</bold></xref>).</p>
</sec>
<sec id="s3_2">
<title>Lipid data and modeling</title>
<p>After quality control, 138 of 150 phospholipid species were analyzed. For each species, a sex-adjusted ordinary least-squares model estimated the association with continuous IAT; multiplicity was controlled within class using Benjamini&#x2013;Hochberg. Lipid species with q&lt;0.30 are summarized in <xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>. Multivariate analysis revealed that while principal component analysis (PCA) showed overlapping distributions, partial least squares discriminant analysis (PLS-DA) indicated a trend of separation by IAT severity (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure S1</bold></xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Lipid species associated with Internet Addiction Tendency (IAT).</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Class</th>
<th valign="middle" align="left">Lipid</th>
<th valign="middle" align="left"><inline-formula>
<mml:math display="inline" id="im6"><mml:mi>&#x3b2;</mml:mi></mml:math></inline-formula></th>
<th valign="middle" align="left">CI_low</th>
<th valign="middle" align="left">CI_high</th>
<th valign="middle" align="left">p</th>
<th valign="middle" align="left">q</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">PC</td>
<td valign="middle" align="left">PC 38:3</td>
<td valign="middle" align="right">10.32</td>
<td valign="middle" align="right">3.25</td>
<td valign="middle" align="right">17.39</td>
<td valign="middle" align="left">&lt;0.001</td>
<td valign="middle" align="right">0.084</td>
</tr>
<tr>
<td valign="middle" align="left">PC</td>
<td valign="middle" align="left">PC 40:4</td>
<td valign="middle" align="right">66.45</td>
<td valign="middle" align="right">14.18</td>
<td valign="middle" align="right">118.73</td>
<td valign="middle" align="right">0.014</td>
<td valign="middle" align="right">0.108</td>
</tr>
<tr>
<td valign="middle" align="left">PE</td>
<td valign="middle" align="left">PE 36:2</td>
<td valign="middle" align="right">-1.33</td>
<td valign="middle" align="right">-2.29</td>
<td valign="middle" align="right">-0.38</td>
<td valign="middle" align="right">0.008</td>
<td valign="middle" align="right">0.042</td>
</tr>
<tr>
<td valign="middle" align="left">PE</td>
<td valign="middle" align="left">PE 36:4</td>
<td valign="middle" align="right">5.00</td>
<td valign="middle" align="right">1.67</td>
<td valign="middle" align="right">8.33</td>
<td valign="middle" align="right">0.005</td>
<td valign="middle" align="right">0.042</td>
</tr>
<tr>
<td valign="middle" align="left">PE</td>
<td valign="middle" align="left">PE 38:3</td>
<td valign="middle" align="right">9.77</td>
<td valign="middle" align="right">2.39</td>
<td valign="middle" align="right">17.16</td>
<td valign="middle" align="right">0.011</td>
<td valign="middle" align="right">0.042</td>
</tr>
<tr>
<td valign="middle" align="left">PE</td>
<td valign="middle" align="left">PE 40:5</td>
<td valign="middle" align="right">13.84</td>
<td valign="middle" align="right">3.47</td>
<td valign="middle" align="right">24.21</td>
<td valign="middle" align="right">0.011</td>
<td valign="middle" align="right">0.042</td>
</tr>
<tr>
<td valign="middle" align="left">PE</td>
<td valign="middle" align="left">PE 40:4</td>
<td valign="middle" align="right">18.98</td>
<td valign="middle" align="right">0.60</td>
<td valign="middle" align="right">37.37</td>
<td valign="middle" align="right">0.043</td>
<td valign="middle" align="right">0.130</td>
</tr>
<tr>
<td valign="middle" align="left">PE</td>
<td valign="middle" align="left">PE 32:1</td>
<td valign="middle" align="right">40.79</td>
<td valign="middle" align="right">-6.18</td>
<td valign="middle" align="right">87.75</td>
<td valign="middle" align="right">0.086</td>
<td valign="middle" align="right">0.216</td>
</tr>
<tr>
<td valign="middle" align="left">PE</td>
<td valign="middle" align="left">PE 36:3</td>
<td valign="middle" align="right">-3.39</td>
<td valign="middle" align="right">-7.52</td>
<td valign="middle" align="right">0.74</td>
<td valign="middle" align="right">0.104</td>
<td valign="middle" align="right">0.223</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Linear regression models were fitted for IAT on each lipid species, adjusted for sex. The table shows the lipid class, outcome (IAT), lipid identifier, regression coefficient (&#x3b2;), 95% confidence interval (CI), p-value, and Benjamini&#x2013;Hochberg adjusted q-value within lipid class. Positive &#x3b2; indicates higher IAT scores with increasing lipid concentration. q: Benjamini&#x2013;Hochberg FDR within lipid class (m as specified in Methods). Lipids with q&lt; 0.05 are considered statistically significant, while those with q&lt; 0.30 are highlighted as suggestive associations.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_3">
<title>Findings concentrated in PE and PC</title>
<p>Four phosphatidylethanolamines met FDR q&lt;0.05 (<xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>): PE 36:2 showed an inverse association with IAT (&#x3b2; = &#x2212;1.33; 95% CI, &#x2212;2.29 to &#x2212;0.38; p=0.008; q=0.042), whereas PE 36:4 (&#x3b2; = 5.00; 1.67 to 8.33; p=0.005; q=0.042), PE 38:3 (&#x3b2; = 9.77; 2.39 to 17.16; p=0.011; q=0.042), and PE 40:5 (&#x3b2; = 13.84; 3.47 to 24.21; p=0.011; q=0.042) were positively associated. Within phosphatidylcholines, PC 38:3 was suggestive (<xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>; &#x3b2; = 10.32; 3.25 to 17.39; p&lt;0.001; q=0.084). PC 40:4 had a large point estimate but wide uncertainty (&#x3b2; = 66.45; 14.18 to 118.73; p=0.014; q=0.108), consistent with sparse information. Additional PE species (e.g., PE 40:4, PE 32:1, PE 36:3) were exploratory (0.05&#x2264;q&lt;0.30). Signals outside PE/PC did not meet the pre-specified q&lt;0.05 threshold.</p>
<p>The volcano plot (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>) summarizes estimates and adjusted evidence across species (red points: q&lt;0.05). <xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2</bold></xref> illustrates the lipid with the minimum q (ties resolved programmatically), showing the scatter with fitted line and IAT across lipid quartiles, and <xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3</bold></xref> further depicts this strongest lipid&#x2013;IAT association using the same two-panel display (scatterplot and IAT by lipid quartiles).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Plasma phospholipid concentration distributions stratified by internet-addiction tendency (IAT &lt; 40 vs &#x2265; 40).Distribution of plasma phospholipid concentrations by Internet-addiction status (IAT &lt; 40 vs &#x2265; 40). Boxes show the median and interquartile range (IQR); whiskers extend to 1.5 &#xd7; IQR; dots represent outliers. Blue boxes correspond to non-addicted participants and red boxes to addicted participants. Statistical contrasts are unadjusted.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-17-1751247-g001.tif">
<alt-text content-type="machine-generated">Volcano plot illustrating results for the Internet Addiction Test (IAT), with BH correction within class. The x-axis represents beta values ranging from negative two hundred to one hundred, while the y-axis represents negative logarithm base ten of q-values from negative zero point two five to one point five. Blue circles denote data points, with key labeled outliers on the positive beta side, including PE 36:2, PE 36:4, PE 38:3, and PE 40:5. Dashed lines indicate thresholds for significance along both axes.</alt-text>
</graphic></fig>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Volcano plot of lipid&#x2013;internet addiction tendency (IAT) associations. This figure shows the &#x3b2; coefficients from linear regression models of lipids predicting Internet Addiction Tendency (IAT). The x-axis indicates standardized &#x3b2;, and the y-axis shows the negative logarithm of the Benjamini&#x2013;Hochberg adjusted q-value (&#x2013;log10 q). Each dot represents one lipid species, colored red when q &#x2264; 0.05 within its lipid class and grey otherwise. Dashed horizontal line corresponds to the significance threshold (q = 0.05). Labels are displayed for significant lipids.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-17-1751247-g002.tif">
<alt-text content-type="machine-generated">Scatter plot and box plot showing Internet Addiction Test scores against PE 36:2 levels. The scatter plot on the left shows a negative correlation (&#x3b2;=-1.33, p=0.00762) with a red trend line. The box plot on the right displays scores by lipid quartile, with statistical significance (p=0.0459), indicating variation across quartiles.</alt-text>
</graphic></fig>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Key lipid associated with internet addiction tendency (IAT). The lipid species with the smallest q-value is illustrated. Left panel: scatterplot with fitted ordinary least squares regression line showing the association between the lipid concentration and IAT score. Right panel: box-and-whisker plot of IAT across quartiles of the lipid. The x-axis indicates lipid quantiles (Q1&#x2013;Q4), and the y-axis indicates IAT score. Together, these plots highlight the strongest observed lipid&#x2013;IAT association. ** p &#x2264; 0.01; * p &#x2264; 0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-17-1751247-g003.tif">
<alt-text content-type="machine-generated">Boxplots comparing two groups, IAT less than 40 and IAT greater than or equal to 40, for different lipid types: PE 40:5, PE 38:3, PE 36:4, PE 36:2, PC 38:3, PC 40:4, PE 40:4, PE 32:4, PE 36:3, and PC 38:4. Each plot shows the distribution with medians and outliers, highlighting differences between the groups.</alt-text>
</graphic></fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>In this cross-sectional pilot of Japanese adolescents (n=34), sex-adjusted per-lipid analyses identified several PE species that were associated with higher IAT scores&#x2014;PE 36:4, PE 38:3, and PE 40:5&#x2014;and one PE species inversely associated (PE 36:2). A PC species (PC 38:3) showed suggestive evidence. Signals centered on PE, with smaller contributions from PC, while other classes did not pass the pre-specified false-discovery threshold.</p>
<p>Prior lipidomics and membrane-lipid studies in neuropsychiatry have described altered phospholipid profiles across mood and cognitive conditions, and a study in internet gaming disorder reported disturbed lipidomic patterns in young men (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B7">7</xref>). Our class-specific pattern&#x2014;concentrated in select PE species with one PC species suggestive&#x2014;extends this literature to a community adolescent sample assessed with the IAT and is consistent with variation in membrane phospholipid composition across behavioral phenotypes. Differences in age, sex composition, biospecimens, platforms, and adjustment sets may account for discrepancies across studies.</p>
<p>Notably, in addition to four PE species (36:4, 38:3, and 40:5), one&#xa0;PC species (38:3) also emerged as a promising correlate of Internet addiction severity. This overlap is biologically plausible, given the metabolic connectivity between PE and PC. In mammalian cells, PE&#xa0;can be sequentially methylated to PC via the phosphatidylethanolamine N-methyltransferase (PEMT) pathway, which is particularly active in neuronal tissues and in the liver. Conversely, both PC and PE serve as substrates for phosphatidylserine synthases (PSS1 and PSS2), which catalyze base-exchange reactions with serine to produce phosphatidylserine (PS); PS can subsequently be decarboxylated back to PE within mitochondria. These interlinked reactions establish a bidirectional metabolic flux between PE and PC, suggesting that perturbations in one phospholipid pool may propagate to the other. Thus, the parallel associations of PE and PC molecular species&#x2014;especially the shared 38:3 species&#x2014;observed here may reflect coordinated remodeling or compensatory homeostatic regulation within the membrane phospholipid network, rather than isolated lipid changes.</p>
<p>In addition to differences among phospholipid classes defined by their hydrophilic headgroups&#x2014;that is, PE and PC&#x2014;the present findings underscore the importance of acyl-chain diversity within each class. A strength of this study lies in its acyl-species-level resolution, which enables the identification of functionally distinct lipid species that share the same headgroup but differ in acyl composition. In neuronal cells, phospholipids play pivotal roles in maintaining membrane fluidity, curvature, and vesicle fusion, processes through which receptor functions and intracellular signaling are dynamically regulated (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). These biophysical properties are critically shaped by the acyl-chain composition of individual phospholipid species. Within each phospholipid class, molecular species differ in the length and saturation of their fatty acyl chains, leading to distinct physical behaviors in the membrane environment. Glycerophospholipids undergo continuous acyl-chain remodeling through the Lands cycle&#x2014;a conserved two-step process involving phospholipase A<sub>2</sub> (PLA<sub>2</sub>)&#x2013;mediated deacylation to generate lysophospholipids, followed by reacylation catalyzed by specific lysophospholipid acyltransferases (LPLATs), including ysophosphatidylcholine acyltransferase (LPCAT) and Lysophosphatidylethanolamine acyltransferase (LPEAT). This remodeling fine-tunes the acyl composition of membrane phospholipid species, thereby modulating membrane curvature, vesicle fusion efficiency, and receptor-mediated signaling. In addition, glycerophospholipids serve as reservoirs for signaling precursors and sources of bioactive lipid mediators: for example, phospholipase C and D (PLC/PLD) reactions generate diacylglycerol (DAG) and phosphatidic acid (PA), while PLA<sub>2</sub> activity releases arachidonic acid for eicosanoid synthesis and produces diverse lysophospholipid signaling molecules (15&#x2013;19). Both the resulting changes in membrane biophysics and in lipid-derived signaling cascades represent processes that underlie synaptic plasticity and may be relevant to the neurobiological alterations associated with Internet addiction.</p>
<p>Against this mechanistic backdrop, the observed pattern&#x2014;positive associations for multiple PE species, represented by PE 38:3, and for PC 38:3, contrasted with an inverse association for PE 36:2&#x2014;may reflect heterogeneous remodeling states rather than a single pathway (<xref ref-type="bibr" rid="B14">14</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>). Such acyl-specific variability likely arises from differences in the enzymatic selectivity or subcellular localization of acyltransferases operating within the Lands cycle. Clinically, while this phospholipid panel is not diagnostic, replication of these associations could guide hypothesis generation, research-oriented risk stratification, and targeted mechanistic experiments.</p>
<p>The sample was small, thus the precision and generalizability are limited. The design was cross-sectional, precluding temporality, that is, IAT may induce some eating behaviors (cite), which reflect as phospholipid profile; alternatively, phospholipid profile may form IAT. IAT was self-reported, and only sex was used for covariate adjustment; residual confounding (e.g., genetic predisposition) is possible. Although multiplicity was controlled within class using Benjamini&#x2013;Hochberg, false positives remain possible and several estimates were imprecise (<xref ref-type="bibr" rid="B12">12</xref>). Batch and technical effects could not be fully evaluated. Findings should be considered exploratory.</p>
<p>In conclusion, specific PE species&#x2014;and to a lesser extent PC 38:3&#x2014;showed the strongest associations with IAT in this pilot. Replication in larger, preregistered, multi-center cohorts with longitudinal designs, richer adjustment, and standardized lipidomics is needed. Future experimental investigations should further elucidate how PE remodeling influences neural signaling and the potential bidirectional interactions between circulating phospholipids and the brain.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>Data are available upon reasonable request, subject to approval by the authors&#x2019; Institutional Ethics Committee.</p></sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by The Institute of Science Tokyo Research Ethics Committee (approval M2017&#x2013;110). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants&#x2019; legal guardians/next of kin.</p></sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>TK: Formal analysis, Writing &#x2013; original draft, Validation, Conceptualization. YT: Writing &#x2013; review &amp; editing. NN: Writing &#x2013; review &amp; editing. SM: Writing &#x2013; review &amp; editing, Investigation, Validation, Methodology. HK: Investigation, Writing &#x2013; review &amp; editing, Validation, Methodology. JS: Investigation, Validation, Writing &#x2013; review &amp; editing, Methodology. TS: Writing &#x2013; review &amp; editing. TF: Writing &#x2013; review &amp; editing, Project administration, Supervision, Funding acquisition.</p></sec>
<ack>
<title>Acknowledgments</title>
<p>We are deeply grateful to the adolescents and their parents/guardians who participated in A&#x2212;CHILD NEXT, to the Adachi City Board of Education and school staff for their support, and to laboratory members who assisted with sample handling and mass spectrometry. We also thank colleagues at the Department of Biochemical Pathophysiology, Institute of Science Tokyo, for access to instrumentation and technical advice.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fpsyt.2026.1751247/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fpsyt.2026.1751247/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Meng</surname> <given-names>SQ</given-names></name>
<name><surname>Cheng</surname> <given-names>JL</given-names></name>
<name><surname>Li</surname> <given-names>YY</given-names></name>
<name><surname>Yang</surname> <given-names>XQ</given-names></name>
<name><surname>Zheng</surname> <given-names>JW</given-names></name>
<name><surname>Chang</surname> <given-names>XW</given-names></name>
<etal/>
</person-group>. 
<article-title>Global prevalence of digital addiction in general population: A systematic review and meta-analysis</article-title>. <source>Clin Psychol Rev</source>. (<year>2022</year>) <volume>92</volume>:<elocation-id>102128</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cpr.2022.102128</pub-id>, PMID: <pub-id pub-id-type="pmid">35150965</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Otsuka</surname> <given-names>Y</given-names></name>
<name><surname>Kaneita</surname> <given-names>Y</given-names></name>
<name><surname>Itani</surname> <given-names>O</given-names></name>
<name><surname>Tokiya</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>Relationship between internet addiction and poor mental health among Japanese adolescents</article-title>. <source>Iran J Public Health</source>. (<year>2020</year>) <volume>49</volume>:<page-range>2069&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.18502/ijph.v49i11.4722</pub-id>, PMID: <pub-id pub-id-type="pmid">33708727</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Schneider</surname> <given-names>M</given-names></name>
<name><surname>Levant</surname> <given-names>B</given-names></name>
<name><surname>Reichel</surname> <given-names>M</given-names></name>
<name><surname>Gulbins</surname> <given-names>E</given-names></name>
<name><surname>Kornhuber</surname> <given-names>J</given-names></name>
<name><surname>Muller</surname> <given-names>CP</given-names></name>
</person-group>. 
<article-title>Lipids in psychiatric disorders and preventive medicine</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2017</year>) <volume>76</volume>:<page-range>336&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.06.002</pub-id>, PMID: <pub-id pub-id-type="pmid">27317860</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Soares</surname> <given-names>JC</given-names></name>
<name><surname>Dippold</surname> <given-names>CS</given-names></name>
<name><surname>Wells</surname> <given-names>KF</given-names></name>
<name><surname>Frank</surname> <given-names>E</given-names></name>
<name><surname>Kupfer</surname> <given-names>DJ</given-names></name>
<name><surname>Mallinger</surname> <given-names>AG</given-names></name>
</person-group>. 
<article-title>Increased platelet membrane phosphatidylinositol-4,5-bisphosphate in drug-free depressed bipolar patients</article-title>. <source>Neurosci Lett</source>. (<year>2001</year>) <volume>299</volume>:<page-range>150&#x2013;2</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0304-3940(00)01775-4</pub-id>, PMID: <pub-id pub-id-type="pmid">11166959</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Guan</surname> <given-names>Z</given-names></name>
<name><surname>Wang</surname> <given-names>Y</given-names></name>
<name><surname>Cairns</surname> <given-names>NJ</given-names></name>
<name><surname>Lantos</surname> <given-names>PL</given-names></name>
<name><surname>Dallner</surname> <given-names>G</given-names></name>
<name><surname>Sindelar</surname> <given-names>PJ</given-names></name>
</person-group>. 
<article-title>Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease</article-title>. <source>J Neuropathol Exp Neurol</source>. (<year>1999</year>) <volume>58</volume>:<page-range>740&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00005072-199907000-00008</pub-id>, PMID: <pub-id pub-id-type="pmid">10411344</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Riya</surname> <given-names>S</given-names></name>
<name><surname>Sultana</surname> <given-names>S</given-names></name>
<name><surname>Daria</surname> <given-names>S</given-names></name>
<name><surname>Proma</surname> <given-names>MA</given-names></name>
<name><surname>Bhuiyan</surname> <given-names>MA</given-names></name>
<name><surname>Haque</surname> <given-names>MA</given-names></name>
<etal/>
</person-group>. 
<article-title>Evaluation of serum lysophosphatidic acid and lysophosphatidylcholine levels in major depressive disorder patients</article-title>. <source>Cureus</source>. (<year>2020</year>) <volume>12</volume>:<fpage>e12388</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7759/cureus.12388</pub-id>, PMID: <pub-id pub-id-type="pmid">33542861</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname> <given-names>CW</given-names></name>
<name><surname>Lee</surname> <given-names>D</given-names></name>
<name><surname>Lee</surname> <given-names>EM</given-names></name>
<name><surname>Park</surname> <given-names>SJ</given-names></name>
<name><surname>Ji</surname> <given-names>DY</given-names></name>
<name><surname>Lee</surname> <given-names>DY</given-names></name>
<etal/>
</person-group>. 
<article-title>Lipidomic profiles disturbed by the internet gaming disorder in young Korean males</article-title>. <source>J Chromatogr B Analyt Technol BioMed Life Sci</source>. (<year>2019</year>) <volume>1</volume>:<page-range>1114&#x2013;5</page-range>:<page-range>119&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jchromb.2019.03.027</pub-id>., PMID: <pub-id pub-id-type="pmid">30951964</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Morioka</surname> <given-names>S</given-names></name>
<name><surname>Nakanishi</surname> <given-names>H</given-names></name>
<name><surname>Yamamoto</surname> <given-names>T</given-names></name>
<name><surname>Hasegawa</surname> <given-names>J</given-names></name>
<name><surname>Tokuda</surname> <given-names>E</given-names></name>
<name><surname>Hikita</surname> <given-names>T</given-names></name>
<etal/>
</person-group>. 
<article-title>A mass spectrometric method for in-depth profiling of phosphoinositide regioisomers and their disease-associated regulation</article-title>. <source>Nat Commun</source>. (<year>2022</year>) <volume>13</volume>:<fpage>83</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-021-27648-z</pub-id>, PMID: <pub-id pub-id-type="pmid">35013169</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="web">
<person-group person-group-type="author"><collab>National Hospital Organization Kurihama Medical and Addiction Center</collab>
</person-group>. (<year>2025</year>). <publisher-loc>IAT</publisher-loc>: 
<publisher-name>Internet Addiction Test</publisher-name>. Available online at: <uri xlink:href="https://kurihama.hosp.go.jp/hospital/screening/iat.html">https://kurihama.hosp.go.jp/hospital/screening/iat.html</uri> (Accessed <date-in-citation content-type="access-date">June 30, 2025</date-in-citation>).
</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fernandez-Villa</surname> <given-names>T</given-names></name>
<name><surname>Molina</surname> <given-names>AJ</given-names></name>
<name><surname>Garcia-Martin</surname> <given-names>M</given-names></name>
<name><surname>Llorca</surname> <given-names>J</given-names></name>
<name><surname>Delgado-Rodriguez</surname> <given-names>M</given-names></name>
<name><surname>Martin</surname> <given-names>V</given-names></name>
</person-group>. 
<article-title>Validation and psychometric analysis of the Internet Addiction Test in Spanish among college students</article-title>. <source>BMC Public Health</source>. (<year>2015</year>) <volume>15</volume>:<fpage>953</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12889-015-2281-5</pub-id>, PMID: <pub-id pub-id-type="pmid">26400152</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tateno</surname> <given-names>M</given-names></name>
<name><surname>Teo</surname> <given-names>AR</given-names></name>
<name><surname>Shiraishi</surname> <given-names>M</given-names></name>
<name><surname>Tayama</surname> <given-names>M</given-names></name>
<name><surname>Kawanishi</surname> <given-names>C</given-names></name>
<name><surname>Kato</surname> <given-names>TA</given-names></name>
</person-group>. 
<article-title>Prevalence rate of Internet addiction among Japanese college students: Two cross-sectional studies and reconsideration of cut-off points of Young&#x2019;s Internet Addiction Test in Japan</article-title>. <source>Psychiatry Clin Neurosci</source>. (<year>2018</year>) <volume>72</volume>:<page-range>723&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/pcn.12686</pub-id>, PMID: <pub-id pub-id-type="pmid">29845676</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Benjamini</surname> <given-names>Y</given-names></name>
<name><surname>Hochberg</surname> <given-names>Y</given-names></name>
</person-group>. 
<article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>. <source>J R Stat Soc Ser B Methodol</source>. (<year>1995</year>) <volume>57</volume>:<fpage>289</fpage>&#x2013;<lpage>300</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.2517-6161.1995.tb02031.x</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Widyanto</surname> <given-names>L</given-names></name>
<name><surname>McMurran</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>The psychometric properties of the internet addiction test</article-title>. <source>Cyberpsychol Behav</source>. (<year>2004</year>) <volume>7</volume>:<page-range>443&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/cpb.2004.7.443</pub-id>, PMID: <pub-id pub-id-type="pmid">15331031</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Vance</surname> <given-names>JE</given-names></name>
</person-group>. 
<article-title>Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids</article-title>. <source>J Lipid Res</source>. (<year>2008</year>) <volume>49</volume>:<page-range>1377&#x2013;87</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1194/jlr.R700020-JLR200</pub-id>, PMID: <pub-id pub-id-type="pmid">18204094</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Calzada</surname> <given-names>E</given-names></name>
<name><surname>Onguka</surname> <given-names>O</given-names></name>
<name><surname>Claypool</surname> <given-names>SM</given-names></name>
</person-group>. 
<article-title>Phosphatidylethanolamine metabolism in health and disease</article-title>. <source>Int Rev Cell Mol Biol</source>. (<year>2016</year>) <volume>321</volume>:<fpage>29</fpage>&#x2013;<lpage>88</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/bs.ircmb.2015.10.001</pub-id>, PMID: <pub-id pub-id-type="pmid">26811286</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bazinet</surname> <given-names>RP</given-names></name>
<name><surname>Laye</surname> <given-names>S</given-names></name>
</person-group>. 
<article-title>Polyunsaturated fatty acids and their metabolites in brain function and disease</article-title>. <source>Nat Rev Neurosci</source>. (<year>2014</year>) <volume>15</volume>:<page-range>771&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrn3820</pub-id>, PMID: <pub-id pub-id-type="pmid">25387473</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shindou</surname> <given-names>H</given-names></name>
<name><surname>Shimizu</surname> <given-names>T</given-names></name>
</person-group>. 
<article-title>Acyl-coa:lysophospholipid acyltransferases</article-title>. <source>J Biol Chem</source>. (<year>2009</year>) <volume>284</volume>:<fpage>1</fpage>&#x2013;<lpage>5</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.R800046200</pub-id>, PMID: <pub-id pub-id-type="pmid">18718904</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2973709">Yu Tian</ext-link>, Qingdao University of Science and Technology, China</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1152875">Manoj Kumar Pandey</ext-link>, Cincinnati Children&#x2019;s Hospital Medical Center, United States</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3337998">Chaoyang Tian</ext-link>, Hainan University, China</p></fn>
</fn-group>
<fn-group>
<fn fn-type="abbr" id="abbrev1">
<label>Abbreviations:</label>
<p>A-CHILD, Adachi Child Health Impact of Living Difficulty study, FDR, False Discovery Rate, IAT, Internet Addiction Test, PC, Phosphatidylcholine, PE, Phosphatidylethanolamine, PI(3,5)P<sub>2</sub>, Phosphatidylinositol-3,5-bisphosphate, PI3P, phosphatidylinositol-3,4,5-trisphosphate.</p>
</fn>
</fn-group>
</back>
</article>